BiotechTube
Home/Investors/Oxford Science Enterprises (OSE)

Oxford Science Enterprises (OSE)

Biotech Investor · 2 portfolio companies

Portfolio
2
Combined Value
$25.7M
Focus Areas
6
Top Stage
Phase 2

Investment Focus

Infectious DiseasesAutoimmune DiseasesOncologyRare Respiratory DiseasesGenetic DisordersPulmonology

Portfolio Companies

CompanyValuation
Barinthus Biotherapeutics$25.7M
AlveoGene—

Frequent Co-Investors

Harrington Discovery Institute at University Hospitals1 sharedOld College Capital (OCC), University of Edinburgh1 shared